Accumulation, organ distribution, and excretion kinetics of ²⁴¹Am in Mayak Production Association workers.
Americium-241 (²⁴¹Am) is the second most significant radiation hazard after ²³⁹Pu at some of the Mayak Production Association facilities. This study summarizes current data on the accumulation, distribution, and excretion of americium compared with plutonium in different organs from former Mayak PA workers. Americium and plutonium were measured in autopsy and bioassay samples and correlated with the presence or absence of chronic disease and with biological transportability of the aerosols encountered at different workplaces. The relative accumulation of ²⁴¹Am was found to be increasing in the workers over time. This is likely from ²⁴¹Pu that increases with time in reprocessed fuel and from the increased concentrations of ²⁴¹Am and ²⁴¹Pu in inhaled alpha-active aerosols. While differences were observed in lung retention with exposures to different industrial compounds with different transportabilities (i.e., dioxide and nitrates), there were no significant differences in lung retention between americium and plutonium within each transportability group. In the non-pulmonary organs, the highest ratios of ²⁴¹Am/²⁴¹Am + SPu were observed in the skeleton. The relative ratios of americium in the skeleton versus liver were significantly greater than for plutonium. The relative amounts of americium and plutonium found in the skeleton compared with the liver were even greater in workers with documented chronic liver diseases. Excretion rates of ²⁴¹Am in ‘‘healthy’’ workers were estimated using bioassay and autopsy data. The data suggest that impaired liver function leads to reduced hepatic ²⁴¹Am retention, leading to increased ²⁴¹Am excretion.
Southern Urals Biophysics Institute, Ozyorsk, Chelyabinsk Region, Russia. suslova@subi.su
Klara G
KG
Suslova
Alexandra B
AB
Sokolova
Alexander V
AV
Efimov
Scott C
SC
Miller
D000328:Adult; D000336:Aerosols; D000368:Aged; D000576:Americium / Q000737:chemistry / Q000493:pharmacokinetics*; D016022:Case-Control Studies; D005260:Female; D006801:Humans; D007221:Industry; D007700:Kinetics; D008107:Liver Diseases / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D009688:Nuclear Reactors / Q000706:statistics & numerical data*; D016273:Occupational Exposure / Q000032:analysis*; D009928:Organ Specificity; D011005:Plutonium / Q000737:chemistry / Q000493:pharmacokinetics; D012426:Russia; D014018:Tissue Distribution
D000336:Aerosols; D011005:Plutonium; D000576:Americium